CymaBay Therapeutics Inc (NASDAQ:CBAY)
| 14.90 Delayed Data As of Sep 29 |  -0.67 / -4.30%Today’s Change | 3.16 Today|||52-Week Range 18.20 | +137.64% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 10.0M | 0.00 | |
| Depreciation And Amortization | 22.0K | 29.0K | 35.0K | 105.0K | ||
| Operating Expenses | Gross Income | -22.0K | -29.0K | -- | -105.0K | |
| General Expenses | 25.9M | 25.6M | 31.3M | 72.4M | ||
| Research And Development | 17.0M | 15.9M | 18.9M | 58.1M | ||
| Total Operating Expenses | 25.9M | 25.6M | 31.3M | 72.5M | ||
| Non-Operating Expenses | Operating Income | -25.9M | -25.6M | -21.3M | -72.5M | |
| Extraordinary Credit | 11.1M | 76.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | 0.00 | -5.8M | -407.0K | ||
| Interest Expense On Debt | 913.0K | 1.3M | 1.1M | 336.0K | ||
| Other Expenses | 0.00 | 0.00 | 0.00 | -3.3M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -15.5M | -26.7M | -27.6M | -72.5M | |
| Net Income | -15.5M | -26.7M | -27.6M | -72.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 18.9M | 23.4M | 34.9M | 57.8M | |
| Shares To Calculate EPS Diluted | 18.9M | 23.4M | 34.9M | 57.8M | ||
| Earnings Per Share | EPS | -$0.83 | -$1.14 | -$0.79 | -$1.26 | |
| EPS Diluted | -$0.83 | -$1.14 | -$0.79 | -$1.25 | ||
